The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
Open accessAbstract
Zinc-finger nuclease, transcription activator-like effector nuclease and CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) are becoming major tools for genome editing. Importantly, knock-in in several non-rodent species has been finally achieved thanks to these customizable nucleases; yet the rates remain to be further improved. We hypothesize that inhibiting non-homologous end joining (NHEJ) or enhancing homology-directed repair (HDR) will improve the nuclease-mediated knock-in efficiency. Here we show that the in vitro application of an HDR enhancer, RS-1, increases the knock-in efficiency by two- to five-fold at different loci, whereas NHEJ inhibitor SCR7 has minimal effects. We then apply RS-1 for animal production and have achieved multifold improvement on the knock-in rates as well. Our work presents tools to nuclease-mediated knock-in animal production, and sheds light on improving gene-targeting efficiencies on pluripotent stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Cermak, T., Doyle, E. L., Christian, M., Wang, L., Zhang, Y., Schmidt, C., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 1,787
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336
Chu, V. T., Weber, T., Wefers, B., Wurst, W., Sander, S., Rajewsky, K., & Kühn, R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3198 · Cited by 1,210
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Lin, S., Staahl, B. T., Alla, R. K., & Doudna, J. A. (2014) · eLife · doi:10.7554/elife.04766 · Cited by 1,189
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System
Bassett, A. R., Tibbit, C., Ponting, C. P., & Liu, J.-L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.020 · Cited by 861
Small molecules enhance CRISPR genome editing in pluripotent stem cells
Yu, C., Liu, Y., Ma, T., Liu, K., Xu, S., Zhang, Y., Liu, H., La Russa, M., Xie, M., Ding, S., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.003 · Cited by 455
Li, W., Teng, F., Li, T., & Zhou, Q. (2013) · Nature Biotechnology · doi:10.1038/nbt.2652 · Cited by 425
The consequences of Rad51 overexpression for normal and tumor cells
Klein, H. L. (2008) · DNA Repair · doi:10.1016/j.dnarep.2007.12.008 · Cited by 356
Srivastava, M., Nambiar, M., Sharma, S., Karki, S. S., Goldsmith, G., Hegde, M., Kumar, S., Pandey, M., Singh, R. K., Ray, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.054 · Cited by 355
Targeted integration in rat and mouse embryos with zinc-finger nucleases
Cui, X., Ji, D., Fisher, D. A., Wu, Y., Briner, D. M., & Weinstein, E. J. (2011) · Nature Biotechnology · doi:10.1038/nbt.1731 · Cited by 312
A Mouse Geneticist’s Practical Guide to CRISPR Applications
Singh, P., Schimenti, J. C., & Bolcun-Filas, E. (2015) · Genetics · doi:10.1534/genetics.114.169771 · Cited by 305
Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2
Dray, E., Etchin, J., Wiese, C., Saro, D., Williams, G. J., Hammel, M., Yu, X., Galkin, V. E., Liu, D., Tsai, M.-S., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1916 · Cited by 172
Effective gene targeting in rabbits using RNA-guided Cas9 nucleases
Yang, D., Xu, J., Zhu, T., Fan, J., Lai, L., Zhang, J., & Chen, Y. E. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt047 · Cited by 163
Self-citationA chemical compound that stimulates the human homologous recombination protein RAD51
Jayathilaka, K., Sheridan, S. D., Bold, T. D., Bochenska, K., Logan, H. L., Weichselbaum, R. R., Bishop, D. K., & Connell, P. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808046105 · Cited by 150
The chromatin remodeler p400 ATPase facilitates Rad51-mediated repair of DNA double-strand breaks
Courilleau, C., Chailleux, C., Jauneau, A., Grimal, F., Briois, S., Boutet-Robinet, E. A., Boudsocq, F., Trouche, D., & Canitrot, Y. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201205059 · Cited by 91
Molecular scissors and their application in genetically modified farm animals
Petersen, B., & Niemann, H. (2015) · Transgenic Research · doi:10.1007/s11248-015-9862-z · Cited by 81
Highly Efficient Targeted Mutagenesis in Mice Using TALENs
Panda, S. K., Wefers, B., Ortiz, O., Floß, T., Schmid, B., Haass, C., Wurst, W., & Kühn, R. (2013) · Genetics · doi:10.1534/genetics.113.156570 · Cited by 74
The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Zhu, Z., González, F., & Huangfu, D. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801185-0.00011-8 · Cited by 66
Machida, S., Takaku, M., Ikura, M., Sun, J., Suzuki, H., Kobayashi, W., Kinomura, A., Osakabe, A., Tachiwana, H., Horikoshi, Y., et al. (2014) · Scientific Reports · doi:10.1038/srep04863 · Cited by 38
Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
Yang, D., Zhang, J., Xu, J., Zhu, T., Fan, Y., Fan, J., & Chen, Y. E. (2013) · Journal of Visualized Experiments · doi:10.3791/50957 · Cited by 32
Self-citationPaffett, K. S., Clikeman, J. A., Palmer, S., & Nickoloff, J. A. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.03.003 · Cited by 30
Recombination Activator Function of the Novel RAD51- and RAD51B-binding Protein, Human EVL
Takaku, M., Machida, S., Hosoya, N., Nakayama, S., Takizawa, Y., Sakane, I., Shibata, T., Miyagawa, K., & Kurumizaka, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807715200 · Cited by 18
Cited by
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
Metadata
- Authors
- Song, J., Yang, D., Xu, J., Zhu, T., Chen, Y. E., & Zhang, J.
- Venue
- Nature Communications
- Published
- 2016-01-28
- Volume
- 7
- Issue
- 1
- Pages
- 10548-10548
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2297811838
- Cited by
- 422
- References
- 28
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.